BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,587,580 | -32.9% | 280,540 | -19.0% | 0.20% | -29.0% |
| Q2 2023 | $15,786,540 | +85.1% | 346,500 | +64.8% | 0.28% | +75.8% |
| Q1 2023 | $8,526,726 | +3960.3% | 210,225 | +6317.1% | 0.16% | +3925.0% |
| Q2 2022 | $210,000 | -17.3% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $254,000 | -9.6% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $281,000 | +6.8% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $263,000 | -0.4% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $264,000 | -4.3% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $276,000 | +4.9% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $263,000 | 0.0% | 3,276 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $263,000 | -6.7% | 3,276 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $282,000 | +6.0% | 3,276 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $266,000 | +10.8% | 3,276 | +13.9% | 0.01% | +75.0% |
| Q4 2019 | $240,000 | -55.1% | 2,876 | -52.9% | 0.00% | -42.9% |
| Q3 2019 | $534,000 | +8.3% | 6,105 | +1.5% | 0.01% | +16.7% |
| Q2 2019 | $493,000 | +0.8% | 6,014 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $489,000 | +23.5% | 6,014 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $396,000 | -10.0% | 6,014 | +5.3% | 0.01% | 0.0% |
| Q3 2018 | $440,000 | -19.6% | 5,714 | -22.9% | 0.01% | -14.3% |
| Q2 2018 | $547,000 | +15.2% | 7,407 | +1.4% | 0.01% | +16.7% |
| Q1 2018 | $475,000 | -4.4% | 7,303 | -5.0% | 0.01% | 0.0% |
| Q4 2017 | $497,000 | -15.9% | 7,691 | -18.3% | 0.01% | -14.3% |
| Q3 2017 | $591,000 | +5.5% | 9,412 | +1.8% | 0.01% | 0.0% |
| Q2 2017 | $560,000 | +21.5% | 9,242 | +3.9% | 0.01% | +16.7% |
| Q1 2017 | $461,000 | +21.6% | 8,898 | +4.1% | 0.01% | +20.0% |
| Q4 2016 | $379,000 | -18.8% | 8,548 | -12.8% | 0.01% | -16.7% |
| Q3 2016 | $467,000 | -44.8% | 9,807 | -47.6% | 0.01% | +20.0% |
| Q2 2016 | $846,000 | -39.5% | 18,714 | -45.1% | 0.01% | -73.7% |
| Q1 2016 | $1,399,000 | -4.9% | 34,064 | -11.7% | 0.02% | -5.0% |
| Q4 2015 | $1,471,000 | +24.1% | 38,564 | +6.9% | 0.02% | +25.0% |
| Q3 2015 | $1,185,000 | -53.0% | 36,064 | 0.0% | 0.02% | -46.7% |
| Q2 2015 | $2,522,000 | -17.5% | 36,064 | -19.2% | 0.03% | -16.7% |
| Q1 2015 | $3,056,000 | +2.4% | 44,614 | +9.6% | 0.04% | +12.5% |
| Q4 2014 | $2,983,000 | +27.1% | 40,701 | +24.5% | 0.03% | +23.1% |
| Q3 2014 | $2,347,000 | +0.4% | 32,704 | +1.2% | 0.03% | +13.0% |
| Q2 2014 | $2,337,000 | -0.8% | 32,329 | +0.9% | 0.02% | -25.8% |
| Q1 2014 | $2,357,000 | +0.8% | 32,029 | -4.8% | 0.03% | 0.0% |
| Q4 2013 | $2,339,000 | -14.5% | 33,629 | -19.2% | 0.03% | -8.8% |
| Q3 2013 | $2,735,000 | -6.4% | 41,629 | -1.3% | 0.03% | -15.0% |
| Q2 2013 | $2,923,000 | – | 42,193 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |